Partner Content Partner Content OPEN Health invest in rare disease OPEN Health invest in rare disease
News Solomon quits as Akari CEO following credit card probe Biotech veteran quits after less than a year in charge
News Takeda to cut IT, marketing and sales jobs after Shire merge... Takeda aiming for $1.4bn savings per year
News NICE asks EUSA pharma to drop price of neuroblastoma drug NICE calls for price cut before possible CDF funding
News Report warns of UK's rare disease 'postcode lottery' There is still a ‘postcode lottery’ for patients getting access to vital rare disease treatments in the UK, according to a new report.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
